Close Menu

NEW YORK (GenomeWeb) – Biocept said today that it has partnered with the Addario Lung Cancer Medical Institute (ALCMI) to evaluate the use of the company's Target Selector liquid biopsy platform in a clinical study of lung cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.